Concepedia

H. Schwende

HS

8

Publications

1.1K

Citations

8

H-Index

1993

Active since

Affiliations

Novartis (United States)(Current)

University Hospital Leipzig

Ospedale Papa Giovanni XXIII

Novartis (Switzerland)

University of Freiburg

H. Schwende is an author at Novartis (United States) specializing in signal transduction, cellular physiology, and cellular biochemistry.

Top concepts

Publications per year

1993–2022

8

Publications

8

Differences in the state of differentiation of THP-1 cells induced by phorbol ester and 1,25-dihydroxyvitamin D3

H. Schwende, Edith Fitzke, Petra Ambs et al. · Journal of Leukocyte Biology · 1996 · 578 citations

Initiation of Sacubitril/Valsartan in Haemodynamically Stabilised Heart Failure Patients in Hospital or Early After Discharge: Primary Results of the Randomised TRANSITION Study

Rolf Wachter, Michele Senni, Jan Bělohlávek et al. · European Journal of Heart Failure · 2019 · 347 citations · Full text

Initiation of Sacubitril/Valsartan Shortly After Hospitalisation for Acutely Decompensated Heart Failure in Patients with Newly Diagnosed ( <i>de novo</i> ) Heart Failure: A Subgroup Analysis of the TRANSITION Study

Michele Senni, Rolf Wachter, Klaus K. Witte et al. · European Journal of Heart Failure · 2019 · 64 citations · Full text

Different roles of protein kinase C-<i>β</i> and -<i>δ</i> in arachidonic acid cascade, superoxide formation and phosphoinositide hydrolysis

Justus Duyster, H. Schwende, Edith Fitzke et al. · Biochemical Journal · 1993 · 36 citations · Full text

Comparative studies of cytotoxicity and the release of TNF-α, nitric oxide, and eicosanoids of liver macrophages treated with lipopolysaccharide and liposome-encapsulated MTP-PE

Peter Dieter, Petra Ambs, Edith Fitzke et al. · The Journal of Immunology · 1995 · 34 citations

Rows per page

1–5 of 8